Faecal haemoglobin can define risk of colorectal neoplasia at surveillance colonoscopy in patients at increased risk of colorectal cancer.
Jayne DigbyShirley ClearyLynne GrayPooja DattDavid R GoudieRobert J C SteeleJudith A StrachanAdam HumphriesCallum G FraserCraig MowatPublished in: United European gastroenterology journal (2020)
In patients at increased risk of CRC under colonoscopy surveillance, a test measuring faecal haemoglobin can provide an objective estimate of the risk of advanced neoplasia, and could enable tailored scheduling of colonoscopy.